Figure A, Analytic framework for treatment of acute gout - Management of Gout

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Shekelle PG, FitzGerald J, Newberry SJ, et al. Management of Gout [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar. (Comparative Effectiveness Reviews, No. 176.)

Management of Gout [Internet].

Show details

Contents

This figure depicts Key Questions 1, 2, and 5 within the context of the PICOTS described in the previous section to create an analytic framework for the treatment of acute gout. The figure begins with the condition of acute gout. Key question 1 addresses the effects and potential harms (adverse events) associated with pharmacological treatment for an acute gout episode (flare), including the use of NSAIDS, corticosteroids (either oral or infused), and/or colchicine. Key question 2 addresses the role of dietary and/or lifestyle modifications, including a low purine diet, alcohol restriction, improved hydration, use of dietary supplements, increased physical activity, and other changes. In the center of the figure, a box lists possible short-term health outcomes, including pain, joint swelling, and tenderness (short-term being defined as 1-2 days to about a week). An additional potential short term harm is the risk for adverse events. Longer-term outcomes, depicted to the far right, include serum uric acid concentrations, pain, joint swelling and tenderness, ADLs, patient global assessment, and recurrence.

Figure AAnalytic framework for treatment of acute gout

ADLs = activities of daily living; KQ = Key Question; sUA = serum uric acid; ULT = urate lowering therapy

From: Executive Summary

Contents

Views

Cite this Page
Shekelle PG, FitzGerald J, Newberry SJ, et al. Management of Gout [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Mar. (Comparative Effectiveness Reviews, No. 176.) Figure A, Analytic framework for treatment of acute gout.
PDF version of this title (2.1M)

Other titles in these collections

Related information

PMC
PubMed Central citations
PubMed
Links to PubMed

Recent Activity

Clear Turn Off Turn On

Figure A, Analytic framework for treatment of acute gout - Management of Gout
Figure A, Analytic framework for treatment of acute gout - Management of Gout
zinc finger BED domain-containing protein 1-like [Gadus morhua]
zinc finger BED domain-containing protein 1-like [Gadus morhua]
gi|1721923954|ref|XP_030220401.1|
Protein
syndecan-2-like [Gadus morhua]
syndecan-2-like [Gadus morhua]
gi|1721989610|ref|XP_030203289.1|
Protein
zinc finger protein 35-like isoform X1 [Gadus morhua]
zinc finger protein 35-like isoform X1 [Gadus morhua]
gi|1721865757|ref|XP_030223442.1|
Protein
LOW QUALITY PROTEIN: zinc finger protein 608-like [Gadus morhua]
LOW QUALITY PROTEIN: zinc finger protein 608-like [Gadus morhua]
gi|1721945166|ref|XP_030227207.1|
Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on